Clinical Trial Update: Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of Abelmoschus Manihot for IgA Nephropathy; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Drugs mentioned

• Abelmoschus Manihot (Abelmoschus manihot)

Snippet

Sponsor: Chen Xiangmei | Conditions: IgA Nephropathy | Phase 4 | Status: UNKNOWN